Diese Veranstaltung wurde abgesagt!
Folgende kommende Veranstaltungen könnten Sie interessieren:
08.11.2020 BCLA UK Conference and Exhibition
20.01.2021 Global Specialty Lens Symposium 2021
23.01.2021 100% Optical
11.06.2021 BCLA Clinical Conference and Exhibition 2021
04.08.2021 Annual Meeting of the British Oculoplastic Surgery Society

9th International Conference on the Tear Film & Ocular Surface (TFOS) 2020

22012 Cernobbio, Italien

9th International Conference on the Tear Film & Ocular Surface (TFOS) 2020

Basic Science and Clinical Relevance

Datum:
09.09.2020, 14:00 - 12.09.2020, 17:00
Veranstalter:
Tear Film & Ocular Surface Society (TFOS)
Kurzbeschreibung:
The 9th International Conference on the Tear Film & Ocular Surface: Basic Science and Clinical Relevance will be held in will occur from 9-12 September 2020, in Cernobbio, Italy. This Conference will be sponsored by TFOS (www.TearFilm.org) and designed to assess the current knowledge and 'state of the art' research on the structure and function of tear film-producing tissues, tears and the ocular surface in health and disease.
Fortbildungspunkte: 

Fachärzte

Max. Teilnehmer: unbegrenzt
Gebühren ab: k.A.
EarlyBird bis 30.06.2020: 650,00 EUR

Hinweis:
Includes Auditorium Access, Welcome Reception, Coffee Breaks and 3 Lunches

Cancellation Policy:
For Conference registration fees, if cancellation is received
* before May 1, 2020: 90% refund
* between May 2, 2020, and June 30, 2020: 50% refund
* after July 1, 2020: no refund

Studenten/-innen

Max. Teilnehmer: unbegrenzt
Gebühren ab: k.A.
EarlyBird bis 30.06.2020: 500,00 EUR

Hinweis:
Includes Auditorium Access, Welcome Reception, Coffee Breaks and 3 Lunches
All Student/ Fellows must send related ID documentation!

Cancellation Policy:
For Conference registration fees, if cancellation is received
* before May 1, 2020: 90% refund
* between May 2, 2020, and June 30, 2020: 50% refund
* after July 1, 2020: no refund

Sonstige

Max. Teilnehmer: unbegrenzt
Gebühren ab: k.A.
EarlyBird bis 30.06.2020: 75,00 EUR

Hinweis:
Early Registration through 30 June 2020 - Guest:
Welcome reception only: 75,- €
Welcome Reception and 3 lunches.: 250,- €

Cancellation Policy:
For Conference registration fees, if cancellation is received
* before May 1, 2020: 90% refund
* between May 2, 2020, and June 30, 2020: 50% refund
* after July 1, 2020: no refund

alle

Max. Teilnehmer: unbegrenzt
Gebühren ab: k.A.

für Referenten

Abstract Thema: 01.06.2020
Hinweis:
Young investigators applying for a Travel Award should submit their Conference abstract no later than Monday, June 1, 2020. Individuals may apply for this Award without first registering for the Conference. Winners will be notified by Monday, June 15, 2020.

Please note that you need to register for the Conference BEFORE sending your Abstract! Abstracts must be submitted via the online form. We will not accept abstracts via email. Submission instructions are available upon conference registration.
Abstract: 26.06.2020
Hinweis:
All abstracts, except those from Travel Award applicants, must be submitted no later than Friday, June 26, 2020. We will let first authors know if their abstract was accepted within two weeks after abstract submission. All submitted abstracts, except those from invited speakers, will be assigned as poster presentations.

Please note that you need to register for the Conference BEFORE sending your Abstract! Abstracts must be submitted via the online form. We will not accept abstracts via email. Submission instructions are available upon conference registration.
Bemerkungen:
Diese Veranstaltung findet jährlich statt und bietet Fortbildungsmöglichkeiten für Fachärzte, Studenten/-innen, andere und Sonstige.
Veranstaltungsnummer: 32160
Gebühren ab:  
verfügbare Plätze: unbegrenzt
Sprache: Englisch
 
Abstract Thema: 01.06.2020
Abstract: 26.06.2020
Vom Veranstalter gemeldetes Programm:

Preliminary Program


Special meeting - Pre-Conference 


Wednesday, September 9  
(2:00 - 4:30 PM)

Unique challenges and unmet needs for the treatment of ocular surface disease in various regions of the world

Moderators – Di Chen (China), Arturo Grau Diez (Chile), Sarah Farrant (UK)

Opening remarks – Piera Versura (Italy)

Introduction
The importance of understanding the unmet needs for the treatment of ocular surface diseases throughout the world – Monica Alves (Brazil)

Presentations
North America (i.e. USA and Canada) - Todd Margolis (USA)
Latin America - Juan Carlos Abad (Colombia)
Europe - Jelle Vehof (The Netherlands)
Africa - Sihem Lazreg (Algeria)
Asia – Shigeru Kinoshita (Japan)
Oceania - Fiona Stapleton (Australia)
Synopsis and closing remarks – Eric Papas (Australia)

 

TFOS 2020 Conference

Thursday, September 10

Opening remarks - Stefano Barabino (Italy)


Conference Address

Moderator – Stefano Barabino (Italy) 

A Lifestyle Epidemic: Ocular Surface Disease – Jennifer P Craig (New Zealand)


Session 1.  Ocular surface disease: What we do to ourselves

Moderators: Leslie O’Dell (USA), Bridgitte Shen Lee (USA)
 
Cosmetics - Alison Ng (Canada)
 
Digital eye strain - James Wolffsohn (UK)  

External environment (e.g. pollution, humidity, sick building syndrome, airconditioning/heating) – Louis Tong (Singapore)

Contact lenses – Mark Willcox (Australia)
 
Depression and stress – Choun-Ki Joo (South Korea) 

Age - Kazuo Tsubota (Japan)


Session 2.  East, West, North, South: Impact of geographic region and ethnicity on the prevalence and management of ocular surface disease

Moderators -  Vatinee Bunya (USA), Afsun Sahin (Turkey)

Fuchs endothelial corneal dystrophy and corneal endothelial diseases  - Jodhbir Mehta (Singapore)

Keratoconus – Farhad Hafezi (Switzerland)

Dry eye disease - Michael TM Wang (New Zealand)

Ocular Allergy – Andrea Leonardi (Italy)

Uncorrected refractive error – Lixia Lou (China)

Pterygium - José Gomes (Brazil)


Session 3.  New insights into the pathophysiology and management of catastrophic ocular surface diseases

Moderators – Takashi Kojima (Japan), Kyung Chul Yoon (South Korea)

Corneal ulcers (e.g. due to bacterial, fungal and parasitic infections) – James Chodosh (USA)

Ocular chemical injuries - Geetha Iyer (India)


Graft versus host disease - Victor L Perez Quinones (USA)

Stevens-Johnson syndrome/toxic epidermal necrolysis - Hajirah Saeed (USA) 

Neurotrophic keratopathy – Harminder Dua (UK) 

Ocular surface tumors – Carol L Karp (USA)  


Session 4. Seeing differently: The meaning of blindness

Moderators – Gerd Geerling (Germany), José Benitez del Castillo Sanchez (Spain) 

Seeing differently: A blind person's perspective on the meaning of blindness - Deborah Tramentozzi (Italy)

Seeing differently: A clinician's perspective on the meaning of blindness – Lotfi Merabet (USA)


Session 5. New approaches for the diagnosis and/or treatment of ocular surface diseases

Moderators –  Georgios Kontadakis (Greece), Edoardo Villani (Italy) 

An algorithm for the preoperative diagnosis and treatment of ocular surface disorders – Christopher E Starr (USA)

Use of exosomes for cornea wound healing  - Ali Djalilian (USA)

Liquid cornea  - Virender Sangwan (India)

Thymosin b4: Resurrection of a small, yet powerful, protein in the treatment of bacterial keratitis - Elizabeth Berger (USA)
 
Proteoglycan 4: Impact on the ocular surface and beyond - Tannin Schmidt (USA)

Restoring ocular surface homeostasis through alteration of autophagy - Gordon Laurie (USA)


Poster Session 1

Moderators –  Enesa Begovic (Bosnia), Adriana Stanila (Romania) 



TFOS i2 Innovation Showcase (early evening)

Moderator – David A Sullivan (USA)

Introduction (4 minutes) – Amy Gallant Sullivan (USA)

Startup company presentations – each 3 minutes, 2 minutes discussion



Friday, September 11


Session 6. Meibomian gland dysfunction update

Moderators - Anthony Bron (UK), Donald Korb (USA)

The prevalence of meibomian gland dysfunction in adults – Jutta Horwath-Winter (Austria)

Prevalence of meibomian gland atrophy in a pediatric population – Preeya Gupta (USA)

Distribution and Characteristics of Meibomian Gland Dysfunction Subtypes – Kyung-Sun Na (South Korea)

Hyperlipidemia induces meibomian gland dysfunction – Wei Li (China)

The role of fibrosis in meibomian gland dysfunction – Christophe Baudouin (France)

Meibomian gland regeneration (hypoxia, ECM & stem cells) - Yang Liu (USA)


Session 7. Possible treatments for meibomian gland dysfunction - What are the data? 

Moderator –  Kaevalin Lekhanont (Thailand), Kelly Nichols (USA)

Intraductal probing – Joseph Ciolino (USA)

Thermal pulsation – Allister G Gibbons (USA)  

Intense pulsed light therapy– Joanne Shen (USA)

Microbelpharon exfoliation – Jaya Siddireddy (Australia)

Eyelid warming devices - William Ngo (Canada)

Quantum molecular resonance electrotherapy - Giulio Ferrari (Italy)


Session 8. Models and biomarkers for ocular surface disease

Moderators – Benjamin Sullivan (USA), Piera Versura (Italy)

Multiscale reverse engineering of the human ocular surface - Jeongyun Seo (USA/Korea)

Key integrator in the lacrimal gland-cornea feedback loop - Alison Kuony (Finland)

Neutrophils, the meibomian gland and a chronic inflammatory model of allergic eye disease – Daniel R Saban (USA)

Role of lymphangiogenesis in the regulation of corneal edema and transparency - Claus Cursiefen (Germany)

Utility of tear biomarkers for ocular surface and systemic diseases – Sarah Hamm-Alvarez (USA)

Regulatory and Developmental Aspects of Biomarkers in the Treatment of Ocular Surface Disease
– Gary Novack (USA)


Session 9. Did you know?

Moderators –  Pasquale Aragona (Italy), Jesús Merayo-Lloves (Spain)

Convergence of artificial intelligence and microelectronics with ocular surface biology and disease – Dimitri Azar (USA)

Disruptive contact lens technologies  – Lyndon Jones (Canada)

The multifaceted role of galectin-3 on the ocular surface – Pablo Argueso (USA) 

Primum non nocere: The challenge of iatrogenic ocular surface disease – Christina Grupcheva (Bulgaria)

Glaucoma treatment: The bane of the ocular surface – Stefano Bonini (Italy)

What happens when corneal epithelial cells become stressed? - W Gregory Sawyer (USA)


Session 10. Risk factors for dry eye disease - What are the data?

Moderators –  Blanka Golebiowski (Australia), Paul Karpecki (USA)

Sleep disorders – Masahiko Ayaki (Japan)

Diabetes – Danielle Robertson (USA)

Office environment – Murat Dogru (Australia)

Oral contraceptives – Meng C Lin (USA)

Demodex - Alex Muntz (New Zealand)

Vitamin D-deficiency - James McMillan (USA)
  

Poster Session 2

Moderators –  Heiko Pult (Germany), Scott Schachter (USA) 


Saturday, September 12


Session 11. Debate

Moderators –  Etty Bitton (Canada), Maria Markoulli (Australia)

Are omega-3 supplements for treating dry eye an e-fish-ent approach or is the evidence de-fish-ent?

De-fish-ent – Penny Asbell (USA)

E-fish-ent – Laurie Downie (Australia)


Session 12. Limbal stem cell deficiency

Moderators – Paolo Rama (Italy), Shigeto Shimmura (Japan)

The promise and challenge of stem cells in regenerative medicine - Graziella Pellegrini (Italy)

Homeostasis of the corneal stem cell niche from a single cell analysis prospective - Majlinda Lako (UK)

Monitoring the activity of limbal stem cells during development, health, disease and after transplantation – Nick Di Girolamo (Australia)

Diagnosis and staging of limbal stem cell deficiency - Sophie Deng (USA)

Advances in the treatment of limbal stem cell deficiency - Sayan Basu (India)

Bioengineered cornea construct - Julie Daniels (UK)


Session 13. What a nerve!

Moderators – Carlos Belmonte (Spain), Jason Nichols (USA)

What is neuropathic pain, and what are the underlying mechanisms? – Anat Galor (USA)

Neuropathic disease beyond the eye - Peter Reeh (Germany)
 
Pain and neuroimmune cell interactions -  Marzia Malcangio (UK) 

Management of neuropathic pain – Pedram Hamrah (USA)

Corneal nerve regeneration in dry eye disease - Sarah Knox (USA)

Does a viral infection make you blink? - Anthony St Leger (USA)


Session 14. Targeting the immune system  

Moderators –  Esen Akpek (USA), Kyoung Yul Seo (South Korea)

Requirement for type I interferon signaling in lacrimal gland autoimmune disease – Scott Lieberman (USA)

Neurological and inflammatory manifestations in Sjögren's syndrome: The role of the kynurenine metabolic pathway - Eduardo Rocha (Brazil)

The mucosal surfaces of both eyes are immunologically linked by a neurogenic inflammatory reflex – Jeremias Galletti (Argentina)

Neutrophil extracellular traps – Sandeep Jain (USA)

Anti-inflammatory and anti-fibrotic effects of human amniotic membrane mesenchymal stem cells – Alejandro Navas (Mexico)

Research priorities for innovation and translation in allergic diseases – Sergio Bonini (Italy)


Session 15. The microbiome: Do we need to keep an eye on it?

Moderators – Eisuke Shimizu (Japan), Jerome Ozkan (Australia)

How and when is symbiosis of a human host with their microbiota established? – Marcus C de Goffau (UK) 

Visions of eye commensals: The known and the unknown about how the microbiome affects eye disease - Rachel Caspi (USA)

Role of microbiota in strengthening ocular mucosal barrier function through secretory IgA– Mihaela Gadjeva (USA)

Protective role of commensal bacteria in Sjögren syndrome - Cintia de Paiva (USA)

Nerves (TRPA1) prevent bacterial adhesion to the corneal surface – Suzi Fleiszig (USA)

Do adenoviruses repurpose bacterial recombination machinery? – Jaya Rajaiya (USA)


Poster Session 3

Moderators – Cecilia Marini (Argentina), Elisabeth Messmer (Germany) 


Closing remarks - David A Sullivan (USA)


 

Veranstaltungsort:
Villa Erba Conference Center
Anschrift:
Largo Luchino Visconti 4
22012 Cernobbio, Italien
Veranstalter:
Tear Film & Ocular Surface Society (TFOS)
Organisation:

JAKA CONGRESSI srl
PCO & CME STANDARD Certified Provider
Id 806 AGENAS - Agenzia Nazionale per i Servizi Sanitari Regionali
Via della Balduina, 88
00136 Rome, ITALY
Ph. (+39) 06 35.49.71.14
Fax. (+39) 06 35.34.15.35 
CME Standard Provider n. 806

Organizer : 

Tear Film & Ocular Surface Society Boston
P.O. Box 130146
US - MA 02113 Boston

 
Hinweis:

 

Registration required. Please contact the organizer for further information.